Status:
WITHDRAWN
Evaluation of the Achieving Depression and Anxiety Patient Centered Treatment (ADAPT) Program
Lead Sponsor:
Kaiser Permanente
Conditions:
Depression
Anxiety
Eligibility:
All Genders
18+ years
Brief Summary
Depression and anxiety are increasingly common conditions for which primary care providers (PCPs) serve as the initial healthcare contact for most patients. Comorbid depression and anxiety result in h...
Eligibility Criteria
Inclusion
- Adult Outcomes Questionnaire (AOQ) score between 10-30
- English-Speaking
Exclusion
- High risk for suicide defined by answer to question 9 on PHQ-9 of 1 or more
- Diagnosis of bipolar disorder
- Diagnosis of a psychotic disorder
- Dementia diagnosis
- Active substance use disorder diagnosis
- Current hospice
- Current home-based palliative care
- Residing in a skilled nursing facility
- Residing in an assisted living facility
- Non-Kaiser Permanente Member
- Established psychiatric care outside of Kaiser Permanente
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04839718
Start Date
April 1 2019
End Date
December 31 2022
Last Update
March 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northern California Division of Research
Oakland, California, United States, 94612